— Know what they know.
Not Investment Advice

EXAS NASDAQ

Exact Sciences Corporation
1W: +1.0% 1M: +1.4% 3M: +3.5% YTD: +3.1% 1Y: +136.9% 3Y: +58.6% 5Y: -19.7%
$104.91
Last traded 2026-03-23 — delisted
NASDAQ · Healthcare · Medical - Diagnostics & Research · $20.0B mcap · 188M float · 1.34% daily turnover · Short 40% of daily vol

Cash Flow Trends

Operating Cash Flow
$491M +133.4% ▲
5Y CAGR: +29.2%
Capital Expenditures
$135M +1.0% ▲
5Y CAGR: +15.9%
Free Cash Flow
$357M +378.6% ▲
5Y CAGR: +37.7%
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$349M +11595.9% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$596M-$624M-$204M-$1.0B-$208M
Depreciation & Amort.$180M$198M$207M$215M$222M
Stock-Based Comp.$253M$207M$231M$215M$218M
Change in Working Capital$111M-$26M-$342K-$56M$122M
Other Non-Cash Items$202M$34M-$76M$876M$140M
Operating Cash Flow-$102M-$224M$156M$211M$491M
— Investing Activities —
Capital Expenditures-$136M-$214M-$124M-$136M-$135M
Acquisitions (Net)-$518M-$15M-$52M-$45M-$75M
Investment Purchases-$1.2B-$174M-$156M-$467M-$196M
Investment Sales$794M$453M$383M$206M$572M
Other Investing-$59M$24M-$250K-$225K$28M
Investing Cash Flow-$1.1B$74M$50M-$442M$195M
— Financing Activities —
Net Debt Issuance-$24M$50M$138M$217M-$249M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$32M$26M$22M-$18M-$117M
Financing Cash Flow$8M$76M$160M$232M-$338M
Net Change in Cash-$1.2B-$73M$367M-$3M$349M
Cash End of Period$316M$243M$610M$607M$956M
Free Cash Flow-$238M-$438M$32M$75M$357M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms